Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
Vision Risks With Weight-Loss Drugs Semaglutide and Topiramate Explored

Vision Risks With Weight-Loss Drugs Semaglutide and Topiramate Explored

A detailed comparison reveals potential vision issues linked to popular weight-loss medications.

Naveen Sankar S's avatar
Naveen Sankar S
Jul 07, 2025
∙ Paid
7

Share this post

Just Healthcare
Just Healthcare
Vision Risks With Weight-Loss Drugs Semaglutide and Topiramate Explored
2
Share
Generated image

Recent research highlights increased risks of vision complications, including optic neuropathy and glaucoma, associated with weight-loss drugs like semaglutide and topiramate, emphasizing the importance of patient-specific treatment choices.

Study Details:

Investigations into the ocular side effects of weight-loss medications have uncovered significant v…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share